Works by CAPECE, UMBERTO
Results: 18
Effects of PCSK9 inhibition on glucose metabolism and β-cell function in humans: a pilot study.
- Published in:
- Frontiers in Endocrinology, 2023, p. 01, doi. 10.3389/fendo.2023.1124116
- By:
- Publication type:
- Article
Dapagliflozin improves myocardial flow reserve in patients with type 2 diabetes: the DAPAHEART Trial: a preliminary report.
- Published in:
- Cardiovascular Diabetology, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12933-022-01607-4
- By:
- Publication type:
- Article
Prediabetes: how pathophysiology drives potential intervention on a subclinical disease with feared clinical consequences.
- Published in:
- Minerva Endocrinology, 2021, v. 46, n. 3, p. 272, doi. 10.23736/S2724-6507.21.03405-9
- By:
- Publication type:
- Article
Pancreaticoduodenectomy model demonstrates a fundamental role of dysfunctional β cells in predicting diabetes.
- Published in:
- Journal of Clinical Investigation, 2021, v. 131, n. 12, p. 1, doi. 10.1172/JCI146788
- By:
- Publication type:
- Article
Erythrocyte Membrane Fluidity and Omega-3 Fatty Acid Intake: Current Outlook and Perspectives for a Novel, Nutritionally Modifiable Cardiovascular Risk Factor.
- Published in:
- Nutrients, 2024, v. 16, n. 24, p. 4318, doi. 10.3390/nu16244318
- By:
- Publication type:
- Article
Physical Activity and Type 2 Diabetes: In Search of a Personalized Approach to Improving β-Cell Function.
- Published in:
- Nutrients, 2023, v. 15, n. 19, p. 4202, doi. 10.3390/nu15194202
- By:
- Publication type:
- Article
Alpha-Lipoic Acid and Glucose Metabolism: A Comprehensive Update on Biochemical and Therapeutic Features.
- Published in:
- Nutrients, 2023, v. 15, n. 1, p. 18, doi. 10.3390/nu15010018
- By:
- Publication type:
- Article
Bile Modulates Secretion of Incretins and Insulin: A Study of Human Extrahepatic Cholestasis.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2019, v. 104, n. 7, p. 2685, doi. 10.1210/jc.2018-02804
- By:
- Publication type:
- Article
Bile Modulates Secretion of Incretins and Insulin: A Study of Human Extrahepatic Cholestasis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Real-world evidence evaluation of LDL-C in hospitalized patients: a population-based observational study in the timeframe 2021–2022.
- Published in:
- Lipids in Health & Disease, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12944-024-02221-x
- By:
- Publication type:
- Article
Dapagliflozin-Induced Myocardial Flow Reserve Improvement is not Associated with HDL Ability to Stimulate Endothelial Nitric Oxide Production.
- Published in:
- Diabetes Therapy, 2024, v. 15, n. 1, p. 257, doi. 10.1007/s13300-023-01491-5
- By:
- Publication type:
- Article
Effect of Dapagliflozin on Myocardial Insulin Sensitivity and Perfusion: Rationale and Design of The DAPAHEART Trial.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 7, p. 2101, doi. 10.1007/s13300-021-01083-1
- By:
- Publication type:
- Article
290-OR: Altered In-Situ Expression of Proinsulin-Insulin in Pancreatic Islets Reflects Metabolic and Molecular Defects in Type 2 Diabetic and Glucose-Intolerant Living Donors.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-290-OR
- By:
- Publication type:
- Article
134-OR: Effects of PCSK9 Inhibitors on Glucose Metabolism and ß-Cell Function in Humans.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-134-OR
- By:
- Publication type:
- Article
2295-PUB: Impaired First-Phase Insulin Secretion Predicts the Development of Hyperglycemia in a Human Model of Acute Beta-Cell Mass Reduction.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-2295-PUB
- By:
- Publication type:
- Article
2110-P: Correlation between Ex Vivo Islet Proteomic Analysis and In Vivo Secretory Function in Humans.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-2110-P
- By:
- Publication type:
- Article
SGLT2 inhibition and adipose tissue metabolism: current outlook and perspectives.
- Published in:
- Cardiovascular Diabetology, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12933-024-02539-x
- By:
- Publication type:
- Article
Dapagliflozin treatment is associated with a reduction of epicardial adipose tissue thickness and epicardial glucose uptake in human type 2 diabetes.
- Published in:
- Cardiovascular Diabetology, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12933-023-02091-0
- By:
- Publication type:
- Article